ISSN (print) 1997-6933     ISSN (online) 2500-2139

MYELOID TUMORS

Vsevolod Gennadevich Potapenko, E.V. Morozova
180-194
Treatment of Aggressive Systemic Mastocytosis and Mast Cell Leukemia. Literature Review and Case Reports
1 April 2024
A.G. Turkina, A.V. Kokhno, N.N. Tsyba, M.A. Gurianova, E.I. Sbityakova, A.V. Bykova, I.S. Nemchenko, Yu.Yu. Vlasova, T.V. Chitanava, A.N. Petrova, O.A. Shukhov, E.Yu. Chelysheva, E.V. Morozova, E.G. Lomaia, Elena Andreevna Kuzmina, E.N. Parovichnikova
54-68
Asciminib in Chronic Myeloid Leukemia Patients Without Therapeutic Alternatives: Results of the MAP (Managed Access Program, NCT04360005) Trial in Russia
20 February 2024
Aleksina Alekseevna Shatilova, E.G. Lomaia, Yu.A. Alekseeva, A.V. Petukhov, V.V. Ivanov, E.K. Antonov, S.V. Efremova, A.I. Reshetova, E.N. Tochenaya, D.V. Motorin, E.N. Tochenaya, A.V. Petrov, T.S. Nikulina, K.V. Bogdanov, D.V. Ryzhkova, Yu.V. Mirolyubova, I.E. Prokop’ev, I.G. Budaeva, L.L. Girshova
69-79
Gilteritinib as a New Option for the Treatment of Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Gene Mutation: A Literature Review and Three Case Reports
20 February 2024
A.G. Turkina, Elena Andreevna Kuzmina
311-320
Treatment Outcomes with Asciminib, the First Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor, in Chronic Myeloid Leukemia Patients with Multiple Resistance to Prior Therapy
20 February 2024
M.M. Kanunnikov, Nikolai Nikolaevich Mamaev, T.L. Gindina, A.I. Shakirova, A.M. Sadykov, S.V. Razumova, S.N. Bondarenko, L.S. Zubarovskaya
387-398
BAALC-Expressing Leukemia Hematopoietic Stem Cells and Their Place in the Study of CBF-Positive Acute Myeloid Leukemias in Children and Adults
20 February 2024